Penumbra Stock (NYSE: PEN) stock price, news, charts, stock research, profile.
Open | $226.070 |
Close | $223.180 |
Volume / Avg. | 387.503K / 348.337K |
Day Range | 222.710 - 228.430 |
52 Wk Range | 180.930 - 348.670 |
Market Cap | $8.638B |
P/E Ratio | 97.578 |
Dividend Yield | - |
Exchange | NYSE |
RSI | 40 |
Short Interest | 8.02% |
Days to Cover | 10.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Penumbra (NYSE: PEN) through any online brokerage.
Other companies in Penumbra’s space includes: Steris (NYSE:STE), Masimo (NASDAQ:MASI), Koninklijke Philips (NYSE:PHG), Smith & Nephew (NYSE:SNN) and Abbott Laboratories (NYSE:ABT).
The latest price target for Penumbra (NYSE: PEN) was reported by Truist Securities on Friday, March 22, 2024. The analyst firm set a price target for 280.00 expecting PEN to rise to within 12 months (a possible 25.46% upside). 34 analyst firms have reported ratings in the last year.
The stock price for Penumbra (NYSE: PEN) is $223.18 last updated Today at March 28, 2024 at 4:02 PM EDT.
There are no upcoming dividends for Penumbra.
Penumbra’s Q1 earnings are confirmed for Tuesday, April 30, 2024.
There is no upcoming split for Penumbra.
Penumbra is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.